Jane P Daniels

No ORCID on file · 13 papers in corpus
rct 2024
BMJ open ·doi:10.1136/bmjopen-2024-088072

OBJECTIVES: To evaluate the cost-effectiveness of long-acting progestogens (LAP), including levonorgestrel-releasing intrauterine system (LNG-IUS) and depot-medroxyprogesterone acetate (DMPA), compared with the combined oral contraceptives …

rct 2024
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2023-079006

OBJECTIVES: To evaluate the clinical effectiveness of long acting progestogens compared with the combined oral contraceptive pill in preventing recurrence of endometriosis related pain. DESIGN: The PRE-EMPT (preventing recurrence of endome…

rct 2023
EClinicalMedicine ·doi:10.1016/j.eclinm.2023.101995

BACKGROUND: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids. We compared the effectiveness of ulipristal acetate …

other 2022
Pain and therapy ·doi:10.1007/s40122-021-00351-z
other 2022
AJOG global reports ·doi:10.1016/j.xagr.2022.100057
rct 2020
Lancet (London, England) ·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

diagnostic-accuracy 2018
Health technology assessment (Winchester, England) ·doi:10.3310/hta22400

BACKGROUND: Chronic pelvic pain (CPP) symptoms in women are variable and non-specific; establishing a differential diagnosis can be hard. A diagnostic laparoscopy is often performed, although a prior magnetic resonance imaging (MRI) scan ma…

rct 2017
Trials ·doi:10.1186/s13063-017-1864-0

BACKGROUND: Endometriosis is associated with the growth of endometrium in ectopic sites mainly within the pelvis. This results in inflammation and scarring, causing pain and impaired quality of life. Endometriotic lesions can be excised or …

rct 2015
Health technology assessment (Winchester, England) ·doi:10.3310/hta19880

BACKGROUND: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. OBJECTIVES: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-rele…

review 2015
Current opinion in obstetrics & gynecology ·doi:10.1097/GCO.0000000000000222

PURPOSE OF REVIEW: Chronic pelvic pain (CPP) has an annual prevalence of 38/1000 in the UK, with coexisting pathologies often present. Diagnostic laparoscopy has long been the gold standard diagnostic test, but with up to 40% showing no abn…

review 2013
Current opinion in obstetrics & gynecology ·doi:10.1097/gco.0000000000000025

PURPOSE OF REVIEW: The term idiopathic is often used to describe a disease with no identifiable cause. It may be a diagnosis of exclusion; however, what specific minimum investigations need to be performed to define idiopathic is not always…

meta-analysis 2011
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/j.1600-0412.2011.01314.x

Chronic pelvic pain (CPP), a common cause of disability in women, is a condition best viewed in the biopsychosocial framework. Psychological interventions are frequently considered alongside medical and surgical treatments. Our objective wa…

other 2010
BMJ (Clinical research ed.) ·doi:10.1136/bmj.c4834

#### Summary points Chronic pelvic pain in women is a debilitating condition that impairs quality of life. Studies using various definitions estimated that its prevalence ranges from 2.1% to 24% of the female population worldwide.1 It is a…